SENSIMET 1 Tab.

SENSIMET 1 Tablet — Metformin Hydrochloride + Rosiglitazone

Overview

SENSIMET 1 combines metformin hydrochloride with rosiglitazone, a thiazolidinedione, in a single tablet for type 2 diabetes management requiring dual-mechanism glycemic control. This combination is generally reserved for patients who need additional insulin-sensitizing action beyond metformin alone, and should only be used under close physician supervision given rosiglitazone's specific cardiovascular safety considerations.

Mechanism of Action

Metformin reduces hepatic glucose output and improves peripheral insulin sensitivity, while rosiglitazone activates PPAR-gamma receptors to enhance insulin sensitivity in adipose tissue, muscle, and liver. Together they target insulin resistance through complementary pathways, often producing greater glycemic control than either agent alone.

Indications

SENSIMET 1 is indicated for type 2 diabetes mellitus in patients who require combination therapy involving both biguanide and thiazolidinedione mechanisms, typically after inadequate control on metformin monotherapy. Use is determined by an endocrinologist or physician familiar with the cardiovascular risk profile of rosiglitazone-containing products.

Dosage and Administration

Dosage must be individualized by the prescribing physician based on glycemic targets, renal function, and cardiovascular risk assessment. Tablets are typically taken with meals to reduce gastrointestinal discomfort. Do not adjust the dose without medical guidance.

Contraindications

Contraindicated in patients with heart failure (NYHA Class III or IV), severe renal or hepatic impairment, metabolic acidosis, and known hypersensitivity to either component. Rosiglitazone carries a recognized risk of fluid retention and cardiovascular events, so it is contraindicated in patients with significant cardiac disease.

Side Effects

Common side effects include gastrointestinal upset from the metformin component, and fluid retention, weight gain, or edema from the rosiglitazone component. Rosiglitazone has been associated with increased cardiovascular risk in some studies, which is why its use is now significantly restricted in many countries and requires careful physician oversight.

Drug Interactions

Concurrent use with insulin may increase the risk of fluid retention and heart failure. Iodinated contrast media require temporary metformin discontinuation. Always disclose your full medication list, especially any heart or kidney medications, to your physician.

Special Precautions

Due to documented cardiovascular safety concerns with rosiglitazone, this medication should only be used when clearly necessary and under regular physician monitoring, including periodic cardiac and liver function assessment. Report any swelling, rapid weight gain, or shortness of breath to your doctor immediately.

Storage

Store below 30°C in a dry place, protected from light. Keep out of reach of children.

Frequently Asked Questions

Q1: Why is rosiglitazone use restricted in some countries?
Rosiglitazone has been linked to increased cardiovascular risk in certain studies, leading several health authorities to restrict its use; it should only be prescribed when the benefits are judged by your physician to outweigh the risks.

Q2: What symptoms should prompt me to contact my doctor while on SENSIMET 1?
Seek medical attention promptly if you notice swelling in your legs or ankles, sudden weight gain, or shortness of breath, as these may indicate fluid retention or heart strain.

Q3: Can SENSIMET 1 be used in patients with heart disease?
No, it is contraindicated in patients with significant heart failure; your physician will assess your cardiac status before prescribing this combination.

Q4: Is regular monitoring required while taking this medication?
Yes, periodic monitoring of cardiac status, liver function, and blood glucose is recommended throughout treatment.

Medical Disclaimer: This information is provided for educational purposes only and does not replace professional medical advice. Always consult a registered physician or pharmacist before starting, stopping, or changing any medication. Dosage and suitability vary by individual health condition.